EU Says No Specific Age Risk For AstraZeneca Coronavirus Vaccine So Far

The European Medicines Agency said however that its safety committee expected to issue an "updated recommendation" on the controversial vaccine after its monthly meeting next week.

Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are investigating further, the EU's drug regulator said Wednesday. The European Medicines Agency (EMA) said however that its safety committee expected to issue an "updated recommendation" on the controversial vaccine after its monthly meeting next week. Germany on Tuesday became the latest in a series of countries to advise against using the AstraZeneca jab for younger people after rare reports of clotting, despite the EMA saying it is safe. "At present the review has not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders, for these very rare events," the Amsterdam-based EMA said in a statement.